Target
Arginase-2, mitochondrial
Ligand
BDBM290380
Substrate
n/a
IC50
125±n/a nM
Citation
 Van Zandt, MJagdmann, GE Arginase inhibitors as therapeutics US Patent  US11389464 Publication Date 7/19/2022 
Target
Name:
Arginase-2, mitochondrial
Synonyms:
ARG2 | ARGI2_HUMAN | Arginase II | Kidney-type arginase | Non-hepatic arginase | Type II arginase
Type:
PROTEIN
Mol. Mass.:
38576.93
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978892
Residue:
354
Sequence:
MSLRGSLSRLLQTRVHSILKKSVHSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREGGHIVYDQLPTPSSPDESENQARVRI
  
Inhibitor
Name:
BDBM290380
Synonyms:
(3R,4S)-3-amino-4-(3-boronopropyl)-1-(3-(4- carboxyphenyl)propyl)pyrrolidine-3-carboxylic acid | US10098902, Example 16 | US10603330, Example 16 | US11389464, Example 16
Type:
Small organic molecule
Emp. Form.:
C17H27BN2O4
Mol. Mass.:
334.218
SMILES:
N[C@]1(CN(CCCc2ccccc2)C[C@@H]1CCCB(O)O)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: